NASDAQ:NBIX - Neurocrine Biosciences, Inc.
$87.55
 $1.85
+2.16%
4:00PM EDT
2019-07-15
Neurocrine Biosciences, Inc. is engaged in discovering and developing pharmaceuticals, in diseases with unmet medical needs, through its research and development (R&D) platform, focused on neurological and endocrine based diseases and disorders. Its three lead late-stage clinical programs are elagolix, which is a gonadotropin-releasing hormone (GnRH) antagonist for endometriosis and uterine fibroids; INGREZZA (valbenazine), which is a vesicular monoamine transporter 2 (VMAT2) inhibitor, for the treatment of movement disorders, and opicapone, which is a selective catechol-O-methyltransferase inhibitor that is an adjunct therapy to preparations of levodopa/Dihydroxyphenylalanine (DOPA) decarboxylase inhibitors for adult patients with Parkinson's disease. Its product pipeline also includes NBI-640756, which targets tremor and NBI-74788, which targets classic congenital adrenal hyperplasia. Its R&D focus is on addressing diseases and disorders of the central nervous and endocrine systems. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  NBIX     avg for
industry  
  avg for
sector  
42 stocks weight:  160. 60   114. 77   204. 78  
42 stocks rank:  836. 00   1. 44 K 810. 33  
# analyst opinions:  16. 00   13. 59   13. 86  
mean recommendation:  1. 80   2. 12   2. 04  

quick ratio:  8. 28   5. 48   1. 89  
current ratio:  8. 79   5. 85   2. 40  

ex-dividend date:     1995-12-28
target price low:  87. 00   82. 72   115. 11  
target price avg:  105. 38   104. 42   138. 02  
target price high:  127. 00   130. 64   159. 47  
1-yr high:  125. 85   110. 27   142. 72  
last close:  85. 70   85. 12   126. 54  
50-day avg:  82. 03   86. 06   122. 35  
200-day avg:  87. 82   88. 76   121. 75  
1-yr low:  68. 32   69. 26   100. 63  
volume:  488. 98 K 3. 51 M 5. 53 M
50-day avg volume:  669. 68 K 3. 21 M 4. 22 M
200-day avg volume:  953. 12 K 3. 04 M 4. 75 M

1-day return:  -0. 29 % -0. 30 % -1. 01 %
this week return:  0. 60 % -2. 16 % -1. 35 %
12-wk return:  9. 27 % 3. 34 % 8. 69 %
52-wk return:  -15. 24 % -1. 76 % 12. 22 %

enterprise value (EV):  7. 89 B 46. 50 B 123. 99 B
market cap:  7. 84 B 40. 77 B 109. 11 B
EBITDA:  91. 23 M 4. 33 B 8. 19 B
enterprise multiple (EV/EBITDA):  86. 51   5. 45   12. 05  
enterprise/revenue (EV/R):  15. 22   50. 46   9. 50  
total revenue:  518. 56 M 10. 21 B 40. 60 B
total debt:  463. 85 M 11. 27 B 17. 58 B
debt/equity:  113. 33   57. 36   120. 25  
net income (common):  -39. 19 M 2. 13 B 4. 27 B

shares outstanding:  91. 28 M 551. 08 M 1. 24 B
shares:  89. 96 M 559. 41 M 1. 22 B
shares short:  4. 14 M 11. 15 M 11. 94 M
shares short prior month:  4. 61 M 9. 31 M 11. 96 M
short ratio:  5. 94   5. 72   3. 43  
short % of float:  6. 10 % 6. 40 % 2. 65 %
total cash/share:  5. 74   11. 00   9. 23  
total cash:  524. 07 M 6. 03 B 6. 01 B
free cash flow:  52. 13 M 3. 02 B 4. 96 B
operating cash flow:  27. 36 M 3. 92 B 5. 99 B

book value:  4. 48   13. 02   27. 49  
price/book:  19. 11   4. 21   8. 80  
gross profits:  393. 45 M 7. 67 B 36. 29 B
operating margins:  16. 67 % -380. 20 % -38. 44 %
EBITDA margins:  17. 59 % 13. 59 % 23. 24 %
profit margins:  -7. 56 % 10. 94 % 14. 00 %
gross margins:  89. 51 % 36. 11 % 55. 16 %

1-yr max volatility:  13. 85 % --- ---
1-yr mean volatility:  2. 09 % 1. 50 % 1. 08 %

1-yr EPS:  -0. 43   2. 12   4. 26  
forward EPS:  2. 78   3. 47   7. 14  
P/E:  -197. 47   2. 15   33. 17  
forward P/E:  30. 92   -4. 03   17. 60  
PE/G:  -2. 09   0. 54   0. 34  
growth:  94. 70 % 263. 03 % 78. 34 %
earnings high:  0. 64   0. 91   1. 70  
earnings avg:  0. 13   0. 71   1. 58  
earnings low:  -1. 30   0. 48   1. 46  
revenue high:  181. 30 M 2. 64 B 11. 26 B
revenue avg:  163. 84 M 2. 58 B 11. 09 B
revenue low:  151. 90 M 2. 54 B 10. 90 B
return on assets:  6. 12 % -2. 31 % 5. 31 %
return on equity:  -10. 13 % -82. 48 % 135. 30 %
revenue growth:  94. 70 % 262. 60 % 72. 94 %
revenue/share:  5. 72   12. 77   61. 38  

beta (1yr vs S&P500):  1. 29   1. 26   0. 91  
sharpe (1yr):  -0. 17   0. 07   0. 77  

held % insiders:  1. 27 % 6. 08 % 3. 31 %
held % institutions:  105. 09 % 78. 36 % 69. 61 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-14 : NBIX
.    145.433 =       145.433 :: --> INITIAL WEIGHT <--
.    - 0.434 =       144.999 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 3.785 =       548.871 :: P/E factor
.    x 0.939 =       515.399 :: PE/G factor
.    x 1.716 =       884.429 :: beta factor
.    x 0.697 =       616.126 :: sharpe factor
.    x 2.498 =      1538.912 :: current ratio factor
.    x 1.066 =      1641.234 :: quick ratio factor
.    x 1.081 =      1774.013 :: short ratio factor
.    x 1.154 =      2046.653 :: return on assets factor
.    x 2.151 =      4401.643 :: revenue growth factor
.    x 1.302 =      5729.368 :: EV/R factor
.    x 1.164 =      6668.654 :: price-to-book factor
.    x 2.229 =     14861.491 :: EBITDA vs industry factor
.    x 1.118 =     16614.308 :: debt-to-revenue factor
.    x 1.012 =     16813.171 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.114 =     35542.782 :: sector+industry 1-year gains factor
.    x 1.033 =     36729.841 :: industry 12-weeks return factor
.    x 1.305 =     47942.494 :: industry 2-weeks return factor
.    x 0.963 =      46152.36 :: company one-year gains+dividend factor
.    x 3.531 =    162981.569 :: company 13 weeks' performance factor
.    x 1.203 =    196022.469 :: 5-day avg > 50-day avg
.    x 0.994 =     194784.44 :: "drift" penalty 2 days ago
.    / 1.883 =    103466.697 :: overall "drift" factor
.    x 0.919 =     95058.102 :: largest single-day jump factor
.    x 0.992 =     94336.456 :: volatility factor
.    x 0.994 =      93758.29 :: 42-day volatility factor
.    x 3.043 =    285330.428 :: notable returns + performance factor
.    x 3.487 =    994873.289 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.    x 1.276 =   1269090.878 :: forward EPS factor
.    x 1.956 =   2482017.296 :: forward P/E factor
.    x 1.182 =   2934858.512 :: industry recommendation factor
.      x 2.8 =   8217224.791 :: company recommendation factor
.    x 1.008 =   8280072.932 :: factor historical industry gain for week 28
.    x 1.153 =   9545358.061 :: target low factor
.     x 1.16 =  11070088.623 :: target mean factor
.    x 1.029 =  11392852.559 :: target high factor
.   x 10.365 = 118081468.944 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =       104.243 :: reduced for readability
.    + 43.14 =       147.382 :: add/subtract for investor sentiment
.   + 13.213 =       160.595 :: earnings report in 12 days
.                               --> FINAL WEIGHT <--
.                    160.595 :: FINAL WEIGHT for NASDAQ:NBIX


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org